Strategies for Multivessel Revascularization in Patients with Diabetes
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND In some randomized trials comparing revascularization strategies for patients with diabetes, coronary-artery bypass grafting (CABG) has had a better outcome than percutaneous coronary intervention (PCI). We sought to discover whether aggressive medical therapy and the use of drug-eluting stents could alter the revascularization approach for patients with diabetes and multivessel coronary artery disease. METHODS In this randomized trial, we assigned patients with diabetes and multivessel coronary artery disease to undergo either PCI with drug-eluting stents or CABG. The patients were followed for a minimum of 2 years (median among survivors, 3.8 years). All patients were prescribed currently recommended medical therapies for the control of low-density lipoprotein cholesterol, systolic blood pressure, and glycated hemoglobin. The primary outcome measure was a composite of death from any cause, nonfatal myocardial infarction, or nonfatal stroke. RESULTS From 2005 through 2010, we enrolled 1900 patients at 140 international centers. The patients' mean age was 63.1±9.1 years, 29% were women, and 83% had three-vessel disease. The primary outcome occurred more frequently in the PCI group (P=0.005), with 5-year rates of 26.6% in the PCI group and 18.7% in the CABG group. The benefit of CABG was driven by differences in rates of both myocardial infarction (P<0.001) and death from any cause (P=0.049). Stroke was more frequent in the CABG group, with 5-year rates of 2.4% in t…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Impressively, these results were consistent across all prespecified subgroups.274,275,292”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“(30-day stroke rate for CABG versus PCI, 1.8% versus 0.3%274)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“as did the individual outcomes of death (16.3% versus 10.9%; P<0.05)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“the primary composite outcome of 5-year rates of death resulting from any cause, nonfatal myocardial infarction, or nonfatal stroke occurred more frequently in the PCI group (26.6% versus 18.7%; P=0.005)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“although stroke was more common after CABG (5.2% versus 2.4%; P=0.03).”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333 · cited 1×
“Of these patients, 25% have diabetes.(1,2) In the Bypass Angioplasty Revascularization Investigation (BARI) trial, patients with diabetes and multivessel disease who underwent coronaryartery bypass grafting (CABG) lived longer than did patients undergoing balloon angioplasty, a finding that led to guideline recommenda…”
BackgroundSerruys, P. W., Morice, M.-C., Kappetein, A. P., Colombo, A., Holmes, D. R., Mack, M. J., Ståhle, E., Feldman, T. E., van den Brand, M., Bass, E. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804626 · Cited by 4,331 · cited 6×
“In this randomized trial, we assigned patients with diabetes and multivessel coronary artery disease to undergo either PCI with drug-eluting stents or CABG.”
ResultInfluentialSelf-citationDeveloped with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI), Authors/Task Force Members, Wijns, W., Kolh, P., Danchin, N., Di Mario, C., Falk, V., Folliguet, T., Garg, S., Huber, K., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq277 · Cited by 3,184
Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis
Rankin, J. (1957) · Scottish Medical Journal · doi:10.1177/003693305700200504 · Cited by 2,506
Self-citationThe SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.
Sianos, G., Morel, M., Kappetein, A. P., Morice, M., Colombo, A., Dawkins, K. D., van den Brand, M., Dyck, N. V., Russell, M. E., Mohr, F. W., et al. (2005) · PubMed · Cited by 2,293
ACC/AHA guidelines for coronary artery bypass graft surgery
Eagle, K. A., Guyton, R. A., Davidoff, R., Ewy, G. A., Fonger, J., Gardner, T. J., Gott, J. P., Herrmann, H. C., Marlow, R. A., Nugent, W. C., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00389-7 · Cited by 1,995
Comparison of Coronary Bypass Surgery with Angioplasty in Patients with Multivessel Disease
(1996) · New England Journal of Medicine · doi:10.1056/nejm199607253350401 · Cited by 1,531
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery
Hillis, L. D., Smith, P. K., Anderson, J. L., Bittl, J. A., Bridges, C. R., Byrne, J. G., Cigarroa, J. E., DiSesa, V. J., Hiratzka, L. F., Hutter, A. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.009 · Cited by 820
Self-citationHlatky, M. A., Boothroyd, D. B., Bravata, D. M., Boersma, E., Booth, J., Brooks, M. M., Carrié, D., Clayton, T. C., Danchin, N., Flather, M., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60552-3 · Cited by 735 · cited 1×
“A comprehensive meta-analysis of trials performed before the introduction of drug-eluting stents showed excess mortality after PCI, as compared with CABG, in patients with diabetes.(20) Although our study was not powered to detect a difference in all-cause mortality, we observed a significantly (P = 0.”
ResultSelf-citationInvestigators, T. B. (1997) · Circulation · doi:10.1161/01.cir.96.6.1761 · Cited by 619
Research works printed but not linked: 1
- Sianos G, 2005, EuroIntervention, 1, 219
Cited by
Items 301–400 of 999
Treatment strategies in ischaemic left ventricular dysfunction: a network meta-analysis
Gaudino, M. F. L., Hameed, I., Khan, F., Tam, D. Y., Rahouma, M., Ruan, Y., Naik, A., Franco, A. D., Demetres, M. R., Petrie, M. C., et al. (2020) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezaa319 · Cited by 43
CABG the clear choice for patients with diabetes and multivessel disease
Bhatt, D. L. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30424-0 · Cited by 38
Percutaneous coronary invervention versus coronary artery bypass grafting: A meta-analysis
Smit, Y., Vlayen, J., Koppenaal, H., Eefting, F. D., Kappetein, A. P., & Mariani, M. A. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.10.112 · Cited by 38
Zhang, H., Yuan, X., Osnabrugge, R. L. J., Meng, D., Gao, H., Zhang, S., Rao, C., Hu, S., & Zheng, Z. (2014) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2014.02.047 · Cited by 40
“Nevertheless, CABG is the treatment of choice for the large majority of DM patients, as it is associated with lower rates of adverse events as compared with percutaneous coronary intervention (PCI) [6–10].”
BackgroundLocker, C., Schaff, H. V., Daly, R. C., Dearani, J. A., Bell, M. R., Frye, R. L., Greason, K. L., Stulak, J. M., Joyce, L. D., Pochettino, A. A., et al. (2016) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2016.03.089 · Cited by 39
“The survival advantage in diabetic patients who had revascularization with CABG was confirmed in the FREEDOM (Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease) trial, which showed significantly lower rates of myocardial infarction and death from any caus…”
ResultIribarne, A., DiScipio, A. W., Leavitt, B. J., Baribeau, Y. R., McCullough, J. N., Weldner, P. W., Huang, Y., Robich, M. P., Clough, R. A., Sardella, G. L., et al. (2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2018.04.121 · Cited by 43
“Although optimal medical management has been clearly established as a cornerstone for treatment of patients with ischemic heart failure, there is less evidence for revascularization options.17-19 The STICH trial initially demonstrated no difference in all-cause mortality between patients with reduced EF randomized to…”
ResultInfluentialSternal wound closure in the current era: the need of a tailored approach
Nenna, A., Nappi, F., Dougal, J., Satriano, U. M., Chello, C., Mastroianni, C., Lusini, M., Chello, M., & Spadaccio, C. (2019) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-019-01204-5 · Cited by 41
Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure
Parikh, P. B., Bhatt, D. L., Bhasin, V., Anker, S. D., Skopicki, H. A., Claessen, B. E. P. M., Fonarow, G. C., Hernandez, A. F., Mehran, R., Petrie, M. C., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.03.310 · Cited by 52
Impact of diabetes on carotid artery revascularization
Hussain, M. A., Bin-Ayeed, S. A., Saeed, O. Q., Verma, S., & Al-Omran, M. (2016) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2015.12.041 · Cited by 37
Resistant in‐stent restenosis in the drug eluting stent era
Theodoropoulos, K. N., Mennuni, M. G., Dangas, G., Meelu, O. A., Bansilal, S., Baber, U., Sartori, S., Kovacic, J. C., Moreno, P., Sharma, S. K., et al. (2016) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26559 · Cited by 37
“Currently, surgical revascularization strategy with CABG seems to be a safe and effective alternative for high-risk profile patients, such as diabetics with complex coronary disease [40].”
MethodSelf-citationPercutaneous coronary intervention in the elderly
Sandhu, K., & Nadar, S. K. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.188 · Cited by 42
Minimally invasive coronary artery bypass grafting
Ruel, M., Une, D., Bonatti, J. O., & McGinn, J. T. (2013) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283653fd1 · Cited by 37
“Nevertheless, coronary artery bypass grafting (CABG) was recently confirmed to be more beneficial than PCI in patients with triple vessel coronary artery disease (CAD), in patients with left main stenosis and diffuse CAD, and in diabetic patients with multivessel CAD [1,2].”
BackgroundNinomiya, K., Serruys, P. W. J. C., Garg, S., Gao, C., Masuda, S., Lunardi, M., Lassen, J. F., BANNING, A. P., Colombo, A., Burzotta, F., et al. (2022) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2022.04.025 · Cited by 37
Self-citationSharma, P. K., Agarwal, S., Ellis, S. G., Goel, S. S., Cho, L., Tuzcu, E. M., Lincoff, A. M., & Kapadia, S. R. (2014) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.113.001107 · Cited by 36
Off-Pump Versus On-Pump Coronary Artery Bypass Grafting
Møller, C. H., & Steinbrüchel, D. A. (2014) · Current Cardiology Reports · doi:10.1007/s11886-013-0455-2 · Cited by 36
Fortuna, D., Nicolini, F., Guastaroba, P., Palma, R. D., Bartolomeo, S. D., Saia, F., Pacini, D., Grilli, R. G., on behalf of RERIC (Regional Registry of Cardiac Surgery), & REAL (Regional Registry of Coronary Angioplasties) Investigators (2013) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezt197 · Cited by 36
Guo, L., Lv, H., & Huang, R. (2020) · Clinical Interventions in Aging · doi:10.2147/cia.s252318 · Cited by 42
Tsang, M. B., Schwalm, J.-D., Gandhi, S., Sibbald, M., Gafni, A., Mercuri, M., Salehian, O., Lamy, A. L., Pericak, D., Jolly, S. S., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.12749 · Cited by 37
Ahn, J.-M., Kang, D., Yun, S., Hur, S., Park, H.-J., Tresukosol, D., Kang, W., Kwon, H., Rha, S., Lim, D., et al. (2022) · Circulation · doi:10.1161/circulationaha.122.062188 · Cited by 25
Fezzi, S., Ding, D., Mahfoud, F., Huang, J., Lansky, A., Tu, S.-X., & Wijns, W. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01014-0 · Cited by 33
Self-citationÖmerovic, E., Råmunddal, T., Pétursson, P., Angerås, O., Rawshani, A., Jha, S., Skoglund, K., Mohammad, M. A., Persson, J., Alfredsson, J., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae700 · Cited by 46
Ahmad, Y., Nijjer, S. S., Cook, C., El‐Harasis, M. A., Graby, J., Petraco, R., Kotecha, T., Baker, C. S. R., Malik, I. S., Bellamy, M., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.109 · Cited by 39
Ogawa, S., Okawa, Y., Sawada, K., Goto, Y., Yamamoto, M., Koyama, Y., Baba, H., & Suzuki, T. (2015) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezv106 · Cited by 38
“strated to be superior to percutaneous therapy in terms of long-term survival in type 2 diabetes mellitus (DM) patients with multivessel disease [1, 2].”
BackgroundMethodYoon, Y., Ahn, J., Kang, D., Park, H., Cho, S., Lee, P. H., Lee, S., Park, S., Park, D., & Park, S. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2019.10.020 · Cited by 38
Percutaneous coronary intervention in nonagenarians: pros and cons.
Biondi‐Zoccai, G., Abbate, A., D’Ascenzo, F., Presutti, D. G., Peruzzi, M., Cavarretta, E., Marullo, A. G. M., Lotrionte, M., & Frati, G. (2013) · Europe PMC (PubMed Central) · doi:10.3969/j.issn.1671-5411.2013.01.013 · Cited by 36
Benedetto, U., Caputo, M., Vohra, H. A., Davies, A., Hillier, J., Bryan, A. J., & Angelini, G. D. (2016) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2016.06.038 · Cited by 35
Gaba, P., Sabik, J. F., Murphy, S. A., Bellavia, A., O’Gara, P. T., Smith, P. K., Serruys, P. W. J. C., Kappetein, A. P., Park, S., Park, D., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.065571 · Cited by 43
López‐de‐Andrés, A., Jiménez‐García, R., Hernández‐Barrera, V., Pérez-Farinós, N., de Miguel-Yanes, J. M., Méndez‐Bailón, M., Jiménez‐Trujillo, I., de Miguel, Á. G., Pino, C. G., & Carrasco‐Garrido, P. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-3 · Cited by 36
Shah, B. N., Chahal, N., Bhattacharyya, S., Li, W., Roussin, I., Khattar, R. S., & Senior, R. (2014) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.01.028 · Cited by 34
Trends in Coronary Revascularization and Ischemic Heart Disease–Related Mortality in Israel
Blumenfeld, O., Na’amnih, W., Shapira‐Daniels, A., Lotan, C., Shohat, T., & Shapira, O. M. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004734 · Cited by 34
PCI Versus CABG in Patients With Type 1 Diabetes and Multivessel Disease
Nyström, T., Sartipy, U., Franzén, S., Eliasson, B., Guðbjörnsdóttir, S., Miftaraj, M., Lagerqvist, B., Svensson, A., & Holzmann, M. J. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.744 · Cited by 40
“Similar to the findings in our study, in the subgroup analyses of patients with diabetes in the SYNTAX study, there was a trend towards an increased all-cause mortality, and a significantly increased cardiac-specific mortality in patients who underwent PCI compared to those who underwent CABG (2).”
BackgroundMethodResultInfluentialKulik, A. (2017) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000458 · Cited by 34
Coronary Bypass Versus Percutaneous Revascularization in Multivessel Coronary Artery Disease
Mulukutla, S. R., Gleason, T. G., Sharbaugh, M. S., Sultan, I. S., Marroquin, O. C., Thoma, F. W., Smith, C., Toma, C., Lee, J. S., & Kilic, A. (2019) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2019.02.064 · Cited by 36
Self-citationExternal Support for Saphenous Vein Grafts in Coronary Artery Bypass Surgery
Goldstein, D. J., Puskas, J. D., Alexander, J. H., Chang, H. L., Gammie, J. S., Marks, M. E., Iribarne, A., Vengrenyuk, Y., Raymond, S., Taylor, B. S., et al. (2022) · JAMA Cardiology · doi:10.1001/jamacardio.2022.1437 · Cited by 34
Self-citationUeng, K., Chiang, C., Chao, T., Wu, Y., Lee, W.-L., Li, Y., Ting, K.-H., Su, C.-H., Lin, H., Su, T., et al. (2023) · PubMed Central · doi:10.6515/acs.202301_39(1).20221103a · Cited by 48
Predictors of contemporary coronary artery bypass grafting outcomes
Weisel, R. D., Nussmeier, N. A., Newman, M. F., Pearl, R. G., Wechsler, A. S., Ambrosio, G., Pitt, B., Clare, R. M., Pieper, K. S., Mongero, L. B., et al. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.08.018 · Cited by 35
Percutaneous Coronary Interventions in the Diabetic Patient: Where Do We Stand?
Bittl, J. A. (2015) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.114.001944 · Cited by 37
Ben‐Gal, Y., Mohr, R., Feit, F., Ohman, E. M., Kirtane, A. J., Xu, K., Mehran, R., & Stone, G. W. (2015) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.114.002032 · Cited by 37
Revascularization Strategies in Patients with Diabetes Mellitus and Acute Coronary Syndrome
Buntaine, A. J., Shah, B., Lorin, J. D., & Sedlis, S. P. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0756-3 · Cited by 36
“1 Department of Medicine, Division of Cardiology, VA New York Harbor Healthcare System and New York University School of Medicine, 227 E 30th St, Office 835, New York, NY 10016, USA Curr Cardiol Rep (2016) 18:79”
BackgroundMethodInfluentialHokkanen, M., Huhtala, H., Laurikka, J. O., & Järvinen, O. (2021) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-021-01527-6 · Cited by 43
“Abbreviations AF: Atrial fibrillation; ASO: Arteriosclerosis obliterans; CABG: Coronary artery bypass grafting; CAD: Coronary artery disease; CCU: Cardiac care unit; COPD: Chronic obstructive pulmonary disease; EQ-5D: EuroQoL; ICU: Intensive care unit; MACCE: Major adverse cardiac and cerebrovascular events; MCS: Ment…”
BackgroundEl tratamiento de síndromes coronarios agudos de ancianos y pacientes con comorbilidades
Savonitto, S., Morici, N., & Servi, S. D. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2014.02.010 · Cited by 38
Reynolds, A. C., & King, N. (2018) · Medicine · doi:10.1097/md.0000000000011941 · Cited by 44
“, SYNTAX;([1]) BARI;([2]) FREEDOM).([3]) One of the reasons”
Outcomes of Participants With Diabetes in the ISCHEMIA Trials
Newman, J. D., Anthopolos, R., Mancini, G. B. J., Bangalore, S., Reynolds, H. R., Kunichoff, D. F., Senior, R., Peteiro, J., Bhargava, B., Garg, P., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.054439 · Cited by 35
Self-citationWu, Z., Cheng, C., Sun, X., Wang, J., Guo, D., Chen, S., Zhang, Y., Liu, X., Liu, L., Zhang, C., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01838-z · Cited by 35
Yates, M. T., Soppa, G. K. R., Valencia, O., Jones, S., Firoozi, S., & Jahangiri, M. (2013) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2013.01.026 · Cited by 33
Song, Z., Shen, L., Zheng, Z., Xu, B., Xiong, H., Li, L., & Hu, S. (2016) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2016.01.049 · Cited by 36
“A recent randomized clinical trial reported better survival with coronary artery bypass grafting (CABG) compared with percutaneous coronary intervention (PCI) for these patients.(3) It is generally believed that the survival superiority of CABG is due mainly to the left internal mammal artery (LIMA) to left anterior d…”
Interventional Options for Coronary Artery Calcification
Tomey, M. I., & Sharma, S. K. (2016) · Current Cardiology Reports · doi:10.1007/s11886-015-0691-8 · Cited by 34
BELLE, E. V., Cosenza, A., Baptista, S. B., Vincent, F., Henderson, J., Santos, L., Ramos, R. B., Pouillot, C., Calé, R., Cuisset, T., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2019.5097 · Cited by 33
Time-Varying Survival Benefit of Radial Artery Versus Vein Grafting: A Multiinstitutional Analysis
Schwann, T. A., Tranbaugh, R. F., Dimitrova, K. R., Engoren, M., Kabour, A., Hoffman, D. M., Geller, C. M., Ko, W., & Habib, R. (2013) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2013.09.096 · Cited by 32
Hoffman, D. M., Dimitrova, K. R., Lucido, D. J., Dincheva, G. R., Geller, C. M., Balaram, S. K., Ko, W., Swistel, D. G., & Tranbaugh, R. F. (2014) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2014.03.044 · Cited by 32
“Revascularization is the established, evidence-based treatment for complex coronary disease and diabetes; the FREEDOM trial [18], the latest in a long series of major trials, has confirmed the superiority of CABG over percutaneous intervention for such patients [19].”
BackgroundTreatment of Acute Coronary Syndromes in the Elderly and in Patients With Comorbidities
Savonitto, S., Morici, N., & Servi, S. D. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2014.02.008 · Cited by 41
Shore, S., Borgerding, J. A., Gylys-Colwell, I., McDermott, K. A., Ho, P. M., Tillquist, M. N., Lowy, E., McGuire, D. K., Stolker, J. M., Arnold, S. V., et al. (2014) · Diabetes Care · doi:10.2337/dc13-1125 · Cited by 33
Benedetto, U., Gaudino, M. F. L., Ng, C., Biondi‐Zoccai, G., D’Ascenzo, F., Frati, G., Girardi, L. N., Angelini, G. D., & Taggart, D. P. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.02.090 · Cited by 32
Kang, S. H., Lee, C. W., Baek, S., Lee, P. H., Ahn, J., Park, D., Kang, S., Lee, S., Kim, Y., Park, S., et al. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.03.261 · Cited by 33
SYNTAX Score and Outcomes of Coronary Revascularization in Diabetic Patients
Kundu, A., Sardar, P., O’Day, K., Chatterjee, S., Owan, T., & Abbott, J. D. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-0971-1 · Cited by 34
Ribichini, F. L., Romano, M., Rosiello, R., Vecchia, L. L., Cabianca, E., Caramanno, G., Milazzo, D., Loschiavo, P., Rigattieri, S., Musarò, S. D., et al. (2013) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2013.05.016 · Cited by 32
Paez, R. P., Hossne, N. A., Santo, J. A. D. E., Berwanger, O. B., Santos, R. H. N., Kalil, R. A. K., Jatene, F. B., Cavalcanti, A. B., Zilli, A. C., Bettiati, L. C., et al. (2019) · Brazilian Journal of Cardiovascular Surgery · doi:10.21470/1678-9741-2018-0313 · Cited by 36
Pathak, S., Lai, F. Y., Miksza, J. K., Petrie, M. C., Roman, M., Murray, S., Dearling, J., Perera, D., & Murphy, G. J. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac670 · Cited by 35
“…(HR) for CABG vs. PCI of 0.7, which falls within the range of treatment effects (0.63–0.74) observed in previous pragmatic RCTs evaluating re-vascularization strategies that have changed clinical practice, 6,20,21 a total of 370 events or 592 participants ( n = 296 in each arm) would be required.”
BackgroundInfluentialHannan, E., Zhong, Y., Berger, P., Walford, G., Curtis, J., Wu, C., Venditti, F. J., Higgins, R., Smith, C. R., Lahey, S., et al. (2014) · American Journal of Cardiology · doi:10.1016/j.amjcard.2013.11.035 · Cited by 32
Self-citationManagement of Coronary Artery Calcium and Coronary CTA Findings
Thomas, D. M., Divakaran, S., Villines, T. C., Nasir, K., Shah, N. R., Slim, A. M., Blankstein, R., & Cheezum, M. K. (2015) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-015-9334-0 · Cited by 34
Biomarkers in Coronary Artery Bypass Surgery: Ready for Prime Time and Outcome Prediction?
Parolari, A., Poggio, P., Myasoedova, V. A., Songia, P., Bonalumi, G., Casado, A. P., Pacini, D., Alamanni, F., & Tremoli, E. (2016) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2015.00039 · Cited by 32
“org the lesion is not treatable by PCI, CABG remains the treatment of choice not only in the case of left main trunk disease, reduced cardiac function or severe coronary disease (1, 2), but also in the case of diabetes (3, 4) and in the majority of patients affected by three-vessel disease (5, 6).”
BackgroundCompelling evidence for coronary-bypass surgery in patients with diabetes.
Hlatky, M. (2012) · New England Journal of Medicine · doi:10.1056/nejme1212278 · Cited by 32
Her, A., Shin, E., Kim, S., Kim, B., Kim, T. H., Sohn, C.-B., Choi, B. J., Park, Y., Cho, J. R., & Jeong, Y. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01853-0 · Cited by 31
“Patients were excluded from the analysis if they had previously undergone CABG; presented with cardiogenic shock, thrombolysis before PCI, single-vessel disease, or suboptimal or failed PCI for target lesions; or were lost to follow-up.”
BackgroundInfluentialGallagher, S., Kapur, A., Lovell, M. J., Jones, D. A., Kirkwood, A. A., Hassan, S., Archbold, A., Wragg, A., Uppal, R., & Yaqoob, M. M. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezt630 · Cited by 32
“multivessel disease have consistently shown reduced rates of major adverse cardiac events in the CABG group, driven by lower rates of repeat revascularization [24], while the future revascularization evaluation in patients with diabetes mellitus: optimal management of multi-vessel disease trial also reported significa…”
ResultZhai, C., Cong, H., Hou, K., Hu, Y., Zhang, J., & Yingyi, Z. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0506-y · Cited by 31
Revascularization for Coronary Artery Disease: Principle and Challenges
Gu, D., Qu, J., Zhang, H., & Zheng, Z. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2517-9_3 · Cited by 45
Cardiac mortality, diabetes mellitus, and multivessel disease in ST elevation myocardial infarction
Burgess, S. N., Juergens, C., Yang, W., Shugman, I., Idris, H., Nguyen, T. L., McLean, A. K., Leung, M., Thomas, L., Robledo, K. P., et al. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.08.021 · Cited by 67
Hybrid Coronary Revascularization Versus Conventional Coronary Artery Bypass Surgery
Hannan, E., Wu, Y., Cozzens, K., Sundt, T., Girardi, L., Chikwe, J., Wechsler, A., Smith, C. R., Gold, J., Lahey, S., et al. (2020) · Circulation. Cardiovascular Interventions · doi:10.1161/circinterventions.120.009386 · Cited by 20
Self-citationThe Concept of the Polypill in the Prevention of Cardiovascular Disease
Wiley, B. M., & Fuster, V. (2014) · Annals of Global Health · doi:10.1016/j.aogh.2013.12.008 · Cited by 33
Self-citationYamaji, K., Shiomi, H., Morimoto, T., Nakatsuma, K., Toyota, T., Ono, K., Furukawa, Y., Nakagawa, Y., Kadota, K., Andò, K., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.020955 · Cited by 33
“01 On insulin therapy* 402(13) 422(17) <0.”
InfluentialValle, J. A., Glorioso, T. J., Bricker, R. S., Barón, A. E., Armstrong, E. J., Bhatt, D. L., Rao, S. V., Plomondon, M. E., Serruys, P. W. J. C., Keppetein, A. P., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.1923 · Cited by 31
Padala, S. K., Sidhu, M. S., & Boden, W. E. (2016) · Springer eBooks · doi:10.1007/978-3-642-37393-0_70-2 · Cited by 30
“Two large randomized trials comparing CABGwith DES in patients with multivessel or left main disease have further studied these populations (Serruys et al. 2009; Farkouh et al. 2012).”
BackgroundMethodImpact of diabetes and early revascularization on the need for late and repeat procedures
Orbach, A., Halon, D. A., Jaffe, R., Rubinshtein, R., Karkabi, B., Flugelman, M. Y., & Zafrir, B. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0669-0 · Cited by 31
“Diabetics have higher prevalence of a more extensive and multivessel CAD and increased plaque burden which is more vulnerable to rupture.”
MethodInfluentialIndividualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease
Qintar, M., Humphries, K. H., Park, J. E., Arnold, S. V., Tang, Y., Jones, P. G., Salisbury, A. C., Kureshi, F., Farkouh, M. E., Fuster, V., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.07.083 · Cited by 32
Self-citationLee, K., Ahn, J., Yoon, Y., Kang, D., Park, S. Y., Ko, E., Park, H., Cho, S., Park, S., Kim, T. O., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015372 · Cited by 31
Revascularization in stable coronary artery disease
Al-Lamee, R. K., Foley, M. J., Rajkumar, C., & Francis, D. P. (2022) · BMJ · doi:10.1136/bmj-2021-067085 · Cited by 37
Feng, S., Li, M. L., Fei, J., Dong, A., Zhang, W., Fu, Y., & Zhao, Y. (2023) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-023-02101-y · Cited by 33
“We did sensitivity test by excluding the study that primarily focused on diabetic patients [26].”
MethodLimitations of Repeat Revascularization as an Outcome Measure
Lamelas, P. M., Belardi, J., Whitlock, R. P., & Stone, G. W. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.10.041 · Cited by 33
Li, Z., Amsterdam, E. A., Young, J. N., Hoegh, H., & Armstrong, E. J. (2015) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2015.06.028 · Cited by 30
Paneni, F. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164113512859 · Cited by 33
Head, S. J., Parasca, C. A., Mack, M. J., Mohr, F. W., Morice, M., Holmes, D. R., Feldman, T. E., Dawkins, K. D., Colombo, A., Serruys, P. W. J. C., et al. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu197 · Cited by 29
“lection changes to establish current preferred revascularization strategies [8–11].”
BackgroundSelf-citationHarskamp, R. E., Walker, P. F., Alexander, J. H., Xian, Y., Liberman, H. A., de Winter, R. J., Vassiliades, T. A., Peterson, E. D., Puskas, J. D., & Halkos, M. E. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.06.027 · Cited by 29
“4 otal grafts (median, IQR) 1 (1,1) 3 (3, 4) 278.”
Overview of cardiovascular stent designs
McCormick, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100496-8.00001-9 · Cited by 29
High-risk percutaneous coronary intervention: how to define it today?
Marzo, V. D., D’Amario, D., Galli, M., Vergallo, R., & Porto, I. (2018) · Minerva Cardioangiologica · doi:10.23736/s0026-4725.18.04679-0 · Cited by 32
Assessment of myocardial viability by cardiac MRI
Al‐Sabeq, B., Nabi, F., & Shah, D. J. (2019) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000656 · Cited by 29
Xie, Q., Huang, J. S. Y., Zhu, K., & Chen, Q. (2021) · Clinical Cardiology · doi:10.1002/clc.23613 · Cited by 39
The N-terminus of HIV-1 Tat protein is essential for Tat-TAR RNA interaction
Chaloin, O., Peter, J., Briand, J., Masquida, B., Des̀granges, C., Muller, S., & Hoebeke, J. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4477-1 · Cited by 36
CABG or stents in coronary artery disease: end of the debate?
Taggart, D. P. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60258-5 · Cited by 29
Shiomi, H., Morimoto, T., Furukawa, Y., Nakagawa, Y., Tazaki, J., Sakata, R., Okabayashi, H., Hanyu, M., Shimamoto, M., Nishiwaki, N., et al. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.03.040 · Cited by 29
“The Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM) trial reported that CABG was superior to PCI with DES in patients with diabetes and advanced (predominantly 3 vessel) coronary artery disease.(17) In the present study, lower risk of CABG rel…”
MethodResultKoshizaka, M., Lópes, R. D., Reyes, E., Gibson, C. M., Schulte, P. J., Hafley, G. E., Hernandez, A. F., Green, J. B., Kouchoukos, N. T., Califf, R. M., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.10.013 · Cited by 29
“In the FREEDOM trial, contemporary CABG and percutaneous coronary intervention (PCI) techniques and ancillary medical therapies were used to determine whether CABG or PCI with drug-eluting stents were superior to revascularization in patients with diabetes and multivessel coronary artery disease.(14) CABG was superior…”
MethodBertoluci, M. C., Netto, A. P., Pires, A. C., Pesaro, A. E. P., Schaan, B. D., Caramelli, B., Polanczyk, C. A., Junior, C. V. S., Gualandro, D. M., Malerbi, D. A. C., et al. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-58 · Cited by 35
Pereira, H., Teles, R. C., Costa, M. A. D. S., da Silva, P. C., Ferreira, R. C., Ribeiro, V. D. G., de Oliveira, R. S., Abreu, P. F. E., Carvalho, H. C., Marques, J. H. S., et al. (2015) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2015.06.005 · Cited by 28
Tazaki, J., Shiomi, H., Morimoto, T., Imai, M., Yamaji, K., Sakata, R., Okabayashi, H., Hanyu, M., Shimamoto, M., Nishiwaki, N., et al. (2013) · EuroIntervention · doi:10.4244/eijv9i4a72 · Cited by 28
Une, D., Al‐Atassi, T., Kulik, A., Voisine, P., May, M. R. L., & Ruel, M. (2014) · Circulation · doi:10.1161/circulationaha.113.008227 · Cited by 29
Gregory, D. A., Scotti, D. J., de Lissovoy, G., Palacios, I. F., Dixon, S. R., Maini, B. S., & O’Neill, W. W. (2013) · PubMed Central · Cited by 29
Bioresorbable scaffold — A magic bullet for the treatment of coronary artery disease?
Brie, D. M., Penson, P. E., Șerban, M.-C., Toth, P. P., Simonton, C. A., Serruys, P. W. J. C., & Banach, M. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.027 · Cited by 30
“31 trial (119), the Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery Les ions (SPIRIT IV) trial (120), the Synergy between PCI with Taxus and Cardiac Surgery) Score for Prediction of Outcomes Af ter Unprotected Left Main Coro…”
Revascularization in stable coronary disease: evidence and uncertainties
Katritsis, D. G., Mark, D. B., & Gersh, B. J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0006-z · Cited by 30
Self-citationArian, F., Amini, M., Mostafaei, S., Rezaei‐Kalantari, K., Avval, A. H., Shahbazi, Z., Kasani, K., Bitarafan‐Rajabi, A., Chatterjee, S., Oveisi, M., et al. (2022) · Journal of Imaging Informatics in Medicine · doi:10.1007/s10278-022-00681-0 · Cited by 29
“For patients with severe conditions such as reduced cardiac function due to left main artery disease [5], diabetic patients [6], and patients suffering from multi-vessel disease [7], CABG is the primary treatment choice.”
BackgroundYamamoto, K., Shiomi, H., Morimoto, T., Watanabe, H., Miyazawa, A., Yamaji, K., Ohya, M., Nakamura, S., Mitomo, S., Suwa, S., et al. (2023) · JACC Asia · doi:10.1016/j.jacasi.2022.12.009 · Cited by 30
Revascularization strategies for patients with stable coronary artery disease
Iqbal, J., & Serruys, P. W. J. C. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12243 · Cited by 30
Metadata
- Authors
- Farkouh, M. E., Domanski, M., Sleeper, L. A., Siami, F. S., Dangas, G., Mack, M., Yang, M., Cohen, D. J., Rosenberg, Y., Solomon, S. D., Desai, A. S., Gersh, B. J., Magnuson, E. A., Lansky, A., Boineau, R., Weinberger, J., Ramanathan, K., Sousa, J. E., Rankin, J., Bhargava, B., Buse, J., Hueb, W., Smith, C. R., Muratov, V., Bansilal, S., King, S., Bertrand, M., & Fuster, V.
- Affiliations
- University of Toronto (CA)
- Icahn School of Medicine at Mount Sinai (US)
- New England Research Institutes (US)
- Cardiovascular Research Foundation (US)
- Baylor University Medical Center (US)
- University of Missouri–Kansas City (US)
- National Heart, Lung, and Blood Institute (US)
- Brigham and Women's Hospital (US)
- Mayo Clinic (US)
- Yale University (US)
- University of British Columbia (CA)
- Instituto Dante Pazzanese de Cardiologia (BR)
- Royal Perth Hospital (AU)
- All India Institute of Medical Sciences (IN)
- University of North Carolina at Chapel Hill (US)
- Universidade de São Paulo (BR)
- NewYork–Presbyterian Hospital (US)
- Université de Lille (FR)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-12-20
- Volume
- 367
- Issue
- 25
- Pages
- 2375-2384
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1946152282
- Cited by
- 1,922
- References
- 28
- Citations by year
- 2026: 75 · 2025: 85 · 2024: 75 · 2023: 97 · 2022: 132 · 2021: 127 · 2020: 130 · 2019: 120 · 2018: 135 · 2017: 150 · 2016: 182 · 2015: 201 · 2014: 207 · 2013: 181 · 2012: 17
- FWCI
- 196.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- Locations
- New England Journal of Medicine (publishedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Scientific Electronic Library Online (São Paulo Research Foundation, Latin American and Caribbean Center on Health Sciences Information, Conselho Nacional de Desenvolvimento Científico e Tecnológico) (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Edwards Lifesciences
- Boston Scientific Corporation
- Insulet Corporation
- Halozyme
- Medicines Company
- Novo Nordisk
- Genentech
- St. Jude Medical
- Abbott Vascular
- National Heart, Lung, and Blood Institute (U01 01HL071988, R01HL092989, U01HL071988, U01 01HL092989, 01HL092989, 01HL071988)
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Keywords
- multivessel coronary artery disease, diabetes mellitus, coronary artery bypass grafting, percutaneous coronary intervention, drug-eluting stents, revascularization strategy, myocardial infarction, stroke, all-cause mortality, FREEDOM trial
- MeSH terms
- Aged, Coronary Artery Bypass, Cardiovascular Diseases, Coronary Artery Disease, Female, Humans, Male, Middle Aged, Myocardial Infarction, Angioplasty, Balloon, Coronary, Stroke, Diabetes Complications, Kaplan-Meier Estimate, Drug-Eluting Stents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.